Vascular site hemostasis in percutaneous extracorporeal membrane oxygenation therapy.

Authors

Kathleen Lamb, Department of Surgery, Thomas Jefferson University HospitalFollow
Hitoshi Hirose, Department of Surgery, Thomas Jefferson University HospitalFollow
Harrsion Pitcher, Department of Surgery, Thomas Jefferson University HospitalFollow
Nicholas Cavarocchi, Department of Surgery, Thomas Jefferson University HospitalFollow

Document Type

Article

Publication Date

2012

Comments

This is a link to an open access article that has been peer reviewed and is published in The Open Cardiovascular and Thoracic Surgery Journal 2012: Volume 5, pp. 8-10. DOI: 10.2174/1876533501205010008. ©Benthan Science Publishers

Abstract

Bleeding is a well described complication of percutaneous extracorporeal membrane oxygenation support (ECMO). In an effort to prevent ongoing percutaneous-cannula blood loss, we tried multiple methods to achieve hemostasis and have obtained the best results with QuikClot® Combat Gauze ^TM (Z-Medica Corp, Wallingford, CT). This product is made of kaolin, white alumina silicate clay, which initiates activation of the intrinsic clotting cascade. We reviewed our experience in 21 ECMO patients and found 5 patients who required 17 applications of QuikClot® Combat Gauze ^TM to percutaneous catheter insertion sites and demonstrated a significant reduction in both localized bleeding complications and the need for blood transfusion. QuikClot Combat Gauze ^TM, used for the dual purpose of a dressing and hemostatic agent, is a simple valuable method to control pericatheter bleeding in the ECMO population with demonstrated cost savings and clinical utility.

Recommended Citation

Lamb, Kathleen; Hirose, Hitoshi; Pitcher, Harrsion; and Cavarocchi, Nicholas, "Vascular site hemostasis in percutaneous extracorporeal membrane oxygenation therapy." (2012). Department of Surgery Faculty Papers. Paper 48.
https://jdc.jefferson.edu/surgeryfp/48